Co-treatment non-small cell lung cancer (NSCLC) cells with 3-deazaneplanocin A (EZH inhibitor) and vorinostat synergistically induced apoptosis in all tested NSCLC cell lines, independently on their EGFR status. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.